0.38
-0.0671(-14.92%)
Currency In USD
| Previous Close | 0.45 |
| Open | 0.4 |
| Day High | 0.4 |
| Day Low | 0.37 |
| 52-Week High | 1.42 |
| 52-Week Low | 0.37 |
| Volume | 3.08M |
| Average Volume | 2.59M |
| Market Cap | 56.07M |
| PE | -1.74 |
| EPS | -0.22 |
| Moving Average 50 Days | 0.58 |
| Moving Average 200 Days | 0.62 |
| Change | -0.07 |
If you invested $1000 in Veru Inc. (VERU) 10 years ago, it would be worth $237.63 as of August 06, 2025 at a share price of $0.38. Whereas If you bought $1000 worth of Veru Inc. (VERU) shares 5 years ago, it would be worth $123.04 as of August 06, 2025 at a share price of $0.38.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Veru Announces Reverse Stock Split
GlobeNewswire Inc.
5 hours ago
MIAMI, FL, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that i
Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th
GlobeNewswire Inc.
Yesterday at 12:30 PM GMT
MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will ho
Veru to Participate in the 2025 BTIG Virtual Biotech Conference
GlobeNewswire Inc.
Jul 22, 2025 12:30 PM GMT
MIAMI, FL, July 22, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that t